Company Cannasouth Limited

Equities

CBD

NZCBDE0009S6

Biotechnology & Medical Research

End-of-day quote New Zealand S.E. 07:00:00 2024-03-24 pm EDT 5-day change 1st Jan Change
0.098 NZD +2.08% Intraday chart for Cannasouth Limited -.--% -26.32%

Business Summary

Cannasouth Limited is a New Zealand-based biopharmaceutical company focused on medicinal cannabis. The Company is vertically integrated, with business activities ranging from the production and supply of cannabis flower, manufacturing of cannabis-based ingredients and finished dosage products. It also offers an online clinic, and related activities, such as research and development, marketing, and sales. The Company provides a range of imported, Cannasouth-branded medicinal cannabis products. Its subsidiaries include Eqalis Pharmaceuticals Limited, Eqalis Innovation Limited, Cannasouth Bioscience Limited, and Cannasouth Cultivation Limited.

Managers

Managers TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 19-10-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chairman 65 18-09-25
Director/Board Member - 21-06-28
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 330,470,590 221,661,258 ( 67.07 %) 0 67.07 %

Shareholders

NameEquities%Valuation
Anthony Ho
0.8170 %
2,700,000 0.8170 % 158 814 $

Company contact information

Cannasouth Ltd.

Level 2, CRV Building Waikato Innovation Park

3216, Hamilton

+

http://www.cannasouth.co.nz
address Cannasouth Limited(CBD)
  1. Stock Market
  2. Equities
  3. CBD Stock
  4. Company Cannasouth Limited